Influenza viruses cause seasonal epidemics and frequent pandemics such as avian influenza viruses H5N1 and H7N9 that resulted in significant morbidity and fatality in humans. We engineered influenza A viruses to carry a gene encoding Gaussia luciferase (IAV-luci) while remaining replication competent. Influenza A virus has 17 serological hemagglutinin (HA) subtypes, we thus generated a series of IAV-luci with different HAs including pandemic H1/California/7/2009, avian influenza H5/Hongkong/482/1997, and H7/Anhui/1/2013. Through the detection of bioluminescent signals, we showed that: 1) Infection of animals with IAV-luci enabled real time visualization of infection status or assessment of drug treatment in living animals; 2) Cultured cells infected with as little as one IAV-luci could be detected for its bioluminescent signals. 3) Neutralizing antibodies to influenza virus from the serum of H7N9 infected patients could be detected within 6 hours for diagnosis and prediction of disease outcome; 4) Neutralizing antibodies secreted by one antibody producing B cell became detectable using IAV-luci, therefore enabled the cloning of monoclonal antibodies at single cell level. 5) An ultrasensitive microneutralization assay was developed that allows the epidemiological study for “hidden” avian influenza virus infections in human population. We believe that engineered bioluminescent influenza viruses will greatly facilitate the serological monitoring of infection, epidemicological study, antiviral drug discovery, especially the search for anti-influenza neutralizing antibodies.
Ling Chen, "Engineered bioluminescent influenza viruses shed light on defense against influenza virus infection (Conference Presentation)," Proc. SPIE 10479, Light-Based Diagnosis and Treatment of Infectious Diseases, 104790E (Presented at SPIE BiOS: January 29, 2018; Published: 14 March 2018); https://doi.org/10.1117/12.2291867.5751477468001.
Conference Presentations are recordings of oral presentations given at SPIE conferences and published as part of the proceedings. They include the speaker's narration with video of the slides and animations. Most include full-text papers. Interactive, searchable transcripts and closed captioning are now available for 2018 presentations, with transcripts for prior recordings added daily.
Search our growing collection of more than 16,000 conference presentations, including many plenaries and keynotes.